Sabby Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Hold |
0
| – | – | – | 153 |
|
|
2017
Q4 | – | Sell |
-52,046
| Closed | -$75K | – | 153 |
|
|
2017
Q3 | $75K | Sell |
52,046
-540,626
| -91% | -$779K | ﹤0.01% | 68 |
|
|
2017
Q2 | $960K | Buy |
592,672
+372,960
| +170% | +$604K | 0.06% | 37 |
|
|
2017
Q1 | $748K | Buy |
219,712
+208,330
| +1,830% | +$709K | 0.04% | 61 |
|
|
2016
Q4 | $59K | Sell |
11,382
-393
| -3% | -$2.04K | ﹤0.01% | 146 |
|
|
2016
Q3 | $297K | Sell |
11,775
-725
| -6% | -$18.3K | 0.01% | 113 |
|
|
2016
Q2 | $309K | Sell |
12,500
-12,365
| -50% | -$306K | 0.02% | 121 |
|
|
2016
Q1 | $720K | Buy |
+24,865
| New | +$720K | 0.04% | 109 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 242 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 262 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 175 |
|
|
2014
Q3 | – | Sell |
-56,000
| Closed | -$1.52M | – | 178 |
|
|
2014
Q2 | $1.52M | Sell |
56,000
-30,005
| -35% | -$814K | 0.07% | 43 |
|
|
2014
Q1 | $2.31M | Sell |
86,005
-128,365
| -60% | -$3.44M | 0.13% | 32 |
|
|
2013
Q4 | $5.27M | Sell |
214,370
-4,955
| -2% | -$122K | 0.34% | 7 |
|
|
2013
Q3 | $7.05M | Sell |
219,325
-19,098
| -8% | -$614K | 0.46% | 6 |
|
|
2013
Q2 | $7.07M | Buy |
+238,423
| New | +$7.07M | 0.47% | 9 |
|